RxDoctor Payments Data

Allan Parr, MD

Interventional Pain Medicine · Covington, LANPI 1194795575

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.9% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional pain medicine clinicians in LA, where the typical reported total is $4,761.

$4,761in general payments, 2019–2025

Across 192 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Nevro Corp.$629
  • Abbott$598
  • Medtronic$346
  • Lundbeck LLC$272
  • Biotronik NRO, Inc.$234
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,757100%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,761 in reported general payments places this provider in the 50th percentile of 57 interventional pain medicine providers in Louisiana.

See all interventional pain medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$182,692
Medicare patients
125
Services billed
2,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ajovy SyringeFremanezumab-Vfrm12$8,564
Buprenorphine20$5,352
Gabapentin311$2,986
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen205$2,476
Pregabalin42$1,739
Tramadol Hcl196$1,192
Tizanidine Hcl68$879
Cyclobenzaprine Hcl65$742
Trazodone Hcl46$408
RizatriptanRizatriptan Benzoate12$308
Duloxetine Hcl17$249
Zonisamide15$153
Baclofen12$153
Amitriptyline Hcl17$148
Meloxicam17$114

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →